Somatuline AutoGel 60mg-SW (Lanreotide Injection) 60mg

Somatuline AutoGel 60mg-SW is a lanreotide injection used for symptom control in neuroendocrine tumors and acromegaly. This 60mg depot formulation provides sustained release for monthly administration. Store between 2-8°C to maintain potency. Ideal for patients seeking long-acting somatostatin analog therapy.

Strength

60mg

Pack Size

Storage

2-8°

Manufacturer / TM Owner

IPSEN PHARMA SCHWEIZ Switzerland

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Somatuline AutoGel 60mg-SW is indicated for the treatment of acromegaly when surgery or radiotherapy are insufficient. It helps manage symptoms like excessive growth hormone production. The medication is also used for gastroenteropancreatic neuroendocrine tumors (GEP-NETs) to control tumor growth and hormone-related symptoms. Patients often ask what is lanreotide injection used for in these conditions.

Side Effects

This long-acting injection provides steady medication release over weeks, helping stabilize hormone levels. Users may experience reduced flushing, diarrhea, or abdominal discomfort associated with neuroendocrine tumors. Some report improved quality of life as symptoms become more manageable. The sustained-release formula minimizes daily medication requirements.

Precautions & Warnings

Keep Somatuline AutoGel 60mg-SW refrigerated between 2-8°C and protect from light. Allow the syringe to reach room temperature for 30 minutes before injection. Do not freeze or shake vigorously. Always use the provided auto-injector device for administration. Discard any unused portion after opening.

Avoid Interactions

Lanreotide may interact with medications that affect heart rhythm, such as antiarrhythmics. Caution is advised when combining with drugs that slow heart rate. Monitor blood sugar levels as lanreotide may affect glucose metabolism. Concomitant use with cyclosporine may require dose adjustments due to potential interaction.

Frequently Asked Questions

This medication is typically given once every 28 days via subcutaneous injection.

Common effects may include injection site reactions, gastrointestinal discomfort, or changes in blood sugar levels.

Prescription medications like this require valid medical authorization for purchase.

Store between 2-8°C in the original packaging and protect from light.

It helps control excessive growth hormone production when other treatments are insufficient.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.